Sign inLaunch App
BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·
Company pair · Other
VS

AliveCor vs MOMA Therapeutics: Valuation, Funding, Trajectory

Other Both private US-headquartered No Canborsa market

AliveCor and MOMA Therapeutics are often weighed against each other in other.

On this pageSide by sideValuation marksWhat each disclosesVerdictFAQ
AliveCorPRIVATE · US
VS
Last valuation$467.19M$350M
Basis Basis undisclosed Basis undisclosed
As ofAug 2022Apr 2023
Employees≈150≈150
On CanborsaNo marketNo market
At a glance
$467.19M
AliveCorSeries F · Aug 2022
$350M
MOMA TherapeuticsApr 2023
A valuation basis is undisclosed — no ratio is scored
Gap
0 of 2
On CanborsaNeither company has a market
VS
Head-to-head · field by field

AliveCor vs MOMA Therapeutics — side by side

Field
AliveCorPRIVATE · FOUNDED 2011
MOMA TherapeuticsPRIVATE · FOUNDED —
VS
Last valuation
$467.19M Basis undisclosed
$350M Basis undisclosed
Valuation date
16 Aug 2022
4 Apr 2023
Named investors
OMREN Khosla Ventures WP Global Partners Qualcomm Ventures
Longitude Capital RA Capital SoftBank Vision Fund 2
Employees (est.)
≈150
≈150
Sector & HQ
— · 🇺🇸 US
— · 🇺🇸 US
Status & market
Private — no Canborsa market
Private — no Canborsa market
Valuation · both companies on one scale

Valuation marks

Each bar is the last disclosed mark — $467.19M for AliveCor (basis undisclosed, Aug 2022) and $350M for MOMA Therapeutics (basis undisclosed, Apr 2023).

AliveCor
$467.19Mbasis undisclosed · Aug 2022
$350Mbasis undisclosed · Apr 2023
ALIVECOR · $467.19M · AUG 2022MOMA THERAPEUTICS · $350M · APR 2023
AliveCor vs MOMA Therapeutics · what each company discloses

What each company discloses, and what it leaves out

AliveCorPRIVATEOther · US · 2011
+Last disclosed mark $467.19M — basis undisclosed, Aug 2022.
+Founded 2011 .
+≈150 employees.
+
+
MOMA TherapeuticsPRIVATEOther · US · —
+Last disclosed mark $350M — basis undisclosed, Apr 2023.
+≈150 employees.
+
+
Verdict

Verdict

The $467.19M tells you…
The $350M tells you…

At least one valuation basis is undisclosed, so the two numbers stay side by side, each with its own chip, and no ratio is scored. Both are private: there is no public quote and no Canborsa market on either name.

Frequently asked questions

How do AliveCor and MOMA Therapeutics compare in valuation?›

AliveCor was last valued at $467.2M in August 2022, and MOMA Therapeutics at $350M in April 2023.

What's the location of AliveCor versus MOMA Therapeutics?›

AliveCor's headquarters is in United States; MOMA Therapeutics' is in United States.

What's the team size at AliveCor versus MOMA Therapeutics?›

AliveCor employs around 150 people; MOMA Therapeutics employs around 150.

What's the IPO status of AliveCor and MOMA Therapeutics?›

AliveCor is private, and MOMA Therapeutics is private.

Same pillar · company pairs

Neighbouring pairs in this sector

AliveCor vs Neurablecompany pair · other›
$467.2Mtop valuation3.9×gap
Hippocratic AI vs OpenRoutercompany pair · other›
$7Btop valuation2.0×gap
AliveCor vs UVeyecompany pair · other›
$467.2Mtop valuation4.7×gap
Hippocratic AI vs Netlifycompany pair · other›
$3.5Btop valuation1.8×gap
Cafe Coffee Day vs MTR Foodscompany pair · other›
$340Mtop valuation1.7×gap
Cambly vs Mythiccompany pair · other›
$350Mtop valuation1.4×gap
Chainguard vs dbt Labscompany pair · other›
$4.2Btop valuation1.2×gap
Attentive vs Certikcompany pair · other›
$7Btop valuation3.5×gap
Keep exploring
More pairs in Other
dbt Labs vs OfferUpcompare · versus›Attentive vs Chainguardcompare · versus›Chainguard vs Hippocratic AIcompare · versus›Attentive vs Collibracompare · versus›All company comparisonsindex›
Learn
Stock perps vs tokenized stocksconcept›RWA perpetualsmarkets · index›Perpetuals vs futuresconcept›What is a perpetual?guide · perpetuals basics›All Learn guideslearn · index›
Listed on Canborsa
SpaceX (SPCX)US equity · perp›Cerebras Systems (CBRS)US equity · perp›NVIDIA (NVDA)US equity · perp›Microsoft (MSFT)US equity · perp›All 86 marketsindex›
Company pair · Other

Trade 86 markets on Canborsa

© Canborsa 2026TermsPrivacy